BEIZRAY (DOCETAXEL) INJECTION, FOR INTRAVENOUS USE Trademark
Trademark Overview
On Monday, December 8, 2025, a trademark application was filed for BEIZRAY (DOCETAXEL) INJECTION, FOR INTRAVENOUS USE with the United States Patent and Trademark Office. The USPTO has given the BEIZRAY (DOCETAXEL) INJECTION, FOR INTRAVENOUS USE trademark a serial number of 99536726. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, April 14, 2026. This trademark is owned by Zhuhai Beihai Biotech Co., Ltd.. The BEIZRAY (DOCETAXEL) INJECTION, FOR INTRAVENOUS USE trademark is filed in the Pharmaceutical Products category with the following description:
Analgesics; Antiemetics; Anti-cancer preparations; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer; Chemical reagents for medical purposes; Medicinal infusions for treating cancer; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicines made of Chinese traditional medicinal herbs; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the treatment of cancer; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders
General Information
| Serial Number | 99536726 |
| Word Mark | BEIZRAY (DOCETAXEL) INJECTION, FOR INTRAVENOUS USE |
| Filing Date | Monday, December 8, 2025 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Tuesday, April 14, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "DOCETAXEL INJECTION, FOR INTRAVENOUS USE" |
| Goods and Services | Analgesics; Antiemetics; Anti-cancer preparations; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer; Chemical reagents for medical purposes; Medicinal infusions for treating cancer; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicines made of Chinese traditional medicinal herbs; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the treatment of cancer; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 8, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Zhuhai Beihai Biotech Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Zhuhai, Guangdong 519090
CN |
Trademark Events
| Event Date | Event Description |
| Monday, December 8, 2025 | NEW APPLICATION ENTERED |
| Monday, December 8, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, April 2, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, April 2, 2026 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, April 13, 2026 | ASSIGNED TO EXAMINER |
| Tuesday, April 14, 2026 | SUSPENSION LETTER WRITTEN |
| Tuesday, April 14, 2026 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, April 14, 2026 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
